Search - tctmd.com

Displaying 61 - 80 of 586

Sort: Relevancy | Date

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Presentation TCT 2021

Prasugrel De-escalation Therapy After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Subgroup Analysis of the HOST-REDUCE-POLYTECH-ACS Randomized Clinical Trial

Presenter: Doyeon Hwang

November 04, 2021

News Conference News TCT 2021

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Yael L. Maxwell

October 22, 2021

News Conference News TCT 2021

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

Yael L. Maxwell

October 15, 2021

Podcast TCTMD Talking Points

The COMPARE CRUSH Trial

September 22, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

Crushing Prasugrel Tabs Ups Platelet Inhibition Following Primary PCI

News Daily News

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Yael L. Maxwell

June 22, 2021

News Conference News ACC 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Yael L. Maxwell

May 26, 2021

News Daily News

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

Todd Neale

April 16, 2021

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Daily News

New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI

Yael L. Maxwell

April 05, 2021

News Daily News

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

L.A. McKeown

April 05, 2021

News Daily News

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

Yael L. Maxwell

March 25, 2021

News Daily News

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

L.A. McKeown

February 26, 2021

News Daily News

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

Todd Neale

February 09, 2021

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

Shelley Wood

November 06, 2020

Advertisement

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Prasugrel De-escalation Therapy After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Subgroup Analysis of the HOST-REDUCE-POLYTECH-ACS Randomized Clinical Trial

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

The COMPARE CRUSH Trial

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

FDA Grants Stroke Prevention Indication to Ticagrelor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content